|1.||Miyazawa, Teruo: 5 articles (08/2013 - 07/2007)|
|2.||Nakagawa, Kiyotaka: 5 articles (08/2013 - 07/2007)|
|3.||Kimura, Toshiyuki: 3 articles (08/2013 - 07/2007)|
|4.||Higuchi, Ohki: 3 articles (05/2013 - 12/2009)|
|5.||Yamagishi, Kenji: 2 articles (05/2013 - 07/2007)|
|6.||Sookwong, Phumon: 2 articles (10/2012 - 12/2009)|
|7.||Vichasilp, Chaluntorn: 2 articles (10/2012 - 12/2009)|
|8.||Kimura, Fumiko: 2 articles (10/2012 - 12/2009)|
|9.||Zheng, Yunfeng: 1 article (01/2015)|
|10.||Kim, Oh Yoen: 1 article (01/2015)|
12/31/2013 - "The silkworm extract powder contain 1-deoxynojirimycin (DNJ), a potent α-glycosidase inhibitor, has therapeutic potency against diabetes mellitus. "
12/01/2009 - "Mulberry 1-deoxynojirimycin (DNJ, a potent alpha-glycosidase inhibitor) has therapeutic potency against diabetes mellitus. "
01/01/2015 - "1-Deoxynojirimycin (DNJ) is widely used for the treatment of diabetes mellitus as an inhibitor of intestinal α-glucosidase. "
10/16/2013 - "Mulberry 1-deoxynojirimycin (DNJ), an inhibitor of α-glucosidase, has been reported to help prevent diabetes mellitus and suppress lipid accumulation. "
10/15/2012 - "Mulberry 1-deoxynojirimycin (DNJ), a potent α-glycosidase inhibitor, has therapeutic potency in the suppression of postprandial blood glucose levels thereby possibly preventing diabetes mellitus. "
05/01/1989 - "A natural substance, 1-deoxynojirimycin, found in mulberry roots and seeds may be effective in the treatment of AIDS infection."
05/01/1999 - "Golgi alpha-mannosidase inhibitors (1-deoxymannojirimycin and swainsonine) prevented the oligosaccharides on the MV glycoproteins from obtaining Endo H resistance, but that did not appear to influence in vitro MV infections, indicating that conversion of oligosaccharide chains into the complex form was not required for the function of the MV glycoproteins. "
04/01/1989 - "We have found that fresh human serum enhances the infectivity of HIV-1 in MT-2 cell infection assays when virus is synthesized in the presence of the mannosidase I inhibitor, 1-deoxymannojirimycin, or the mannosidase II inhibitor, swainsonine, but has no enhancing effect on virus synthesized in the presence of the glucosidase I inhibitors, castanospermine and 1-deoxynojirimycin, or the glucosidase II inhibitor, bromoconduritol. "
|3.||Acquired Immunodeficiency Syndrome (AIDS)
01/01/2015 - "The aim of this study was to determine whether 1-deoxynojirimycin (DNJ) isolated from Bacillus subtilis MORI beneficially influences lipid metabolism and mitochondrial function in the liver of mice fed a high-fat diet in addition to the anti-obesity properties of DNJ. "
08/15/2013 - "In this study, the anti-obesity effect of 1-deoxynojirimycin (DNJ) was examined in the diet-induced obese mouse model. "
08/15/2013 - "Intake of mulberry 1-deoxynojirimycin prevents diet-induced obesity through increases in adiponectin in mice."
09/01/2001 - "The possibility of preventing the onset of diabetes and obesity using natural dietary supplements containing 1-deoxynojirimycin and other alpha-glucosidase inhibitors in high concentration is of great potential interest."
|5.||Glycogen Storage Disease Type II (Pompe's Disease)
|2.||Blood Glucose (Blood Sugar)
|3.||1-Deoxynojirimycin (1 Deoxynojirimycin)
|8.||alpha-Glucosidases (Acid Maltase)